954 — Changmao Biochemical Engineering Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$164.21m
- HK$675.77m
- CNY584.79m
Annual cashflow statement for Changmao Biochemical Engineering Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 17.2 | 84.4 | 87.6 | -58.6 | -67.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 14.9 | -86.9 | 29.2 | 61.5 | 29.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.89 | -33.7 | -129 | -46 | -37.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 58.9 | -6.94 | 19.6 | -2.35 | -32.3 |
| Capital Expenditures | -79.1 | -252 | -224 | -139 | -64 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 86.3 | 107 | 2.81 | 17.1 | 31.4 |
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 7.15 | -145 | -221 | -122 | -32.5 |
| Financing Cash Flow Items | — | — | -0.66 | — | 10.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -49.8 | 76.7 | 200 | 154 | 33.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14.4 | -75.5 | 1.81 | 29.6 | -31.6 |